Chemosensitivity and cytokine sensitivity of malignant mesothelioma
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (6) , 420-426
- https://doi.org/10.1007/bf00685817
Abstract
Summary Malignant mesothelioma arises in serosal tissues, is locally invasive, and is usually resistant to chemotherapeutic agents used clinically. To determine whether resistance to cytotoxic drugs was an inherent characteristic of mesothelioma cells, we performed in vitro chemosensitivity testing on five fully characterised human malignant mesothelioma cell lines and, for comparison, on three lines representative of clinically drug-resistant solidtissue carcinomas using the MTT (tetrazolium bromide) assay system. Mesothelioma cell lines were intrinsically resistant to eight common antineoplastic drugs, with concentrations that produced a 50% reduction in optical density (IC50 values) for all drugs being equivalent, if not higher, for mesothelioma cell lines as compared with lung and colon carcinoma cell lines. We then investigated the direct anti-mesothelioma activity of recombinant human cytokines with their antineoplastic properties. All five mesothelioma cell lines were resistant to tumour necrosis factor, but they displayed varying degrees of sensitivity to interferons (IFNs). IFNγ directly inhibited the growth of two of five mesothelioma lines. IFNα displayed little activity against four of five mesothelioma lines. The mesothelioma cells that were sensitive to IFNα were resistant to IFNγ, indicating that sensitivity to IFNs is not a genetic characteristic of malignant mesothelioma cells. Significant interactions between cytokines in combination were not observed.Keywords
This publication has 26 references indexed in Scilit:
- Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusionsInternational Journal of Cancer, 1991
- Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesotheliomaClinical Immunology and Immunopathology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Mechanism of multidrug resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- Antiproliferative Effects Exerted by Recombinant Human Tumor Necrosis Factor-a (TNF-α) and Interferon-y (IFN-γ) on Human Pancreatic Tumor Cell LinesPancreas, 1988
- Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicityInternational Journal of Immunopharmacology, 1988
- Mortality in miners and millers of crocidolite in Western Australia.Occupational and Environmental Medicine, 1988
- Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experienceCancer, 1983
- The Pathogenesis of Asbestos-Associated DiseasesNew England Journal of Medicine, 1982
- Conventional Treatment and its Effect on Survival of Malignant Pleural Mesothelioma in Western AustraliaAustralian and New Zealand Journal of Medicine, 1982